These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 18302874)
1. Does the consent of the patients have a role to play in formulating a treatment policy? Kango M; Baboo KS Trop Doct; 2008 Jan; 38(1):56-7. PubMed ID: 18302874 [TBL] [Abstract][Full Text] [Related]
2. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania. Tarimo DS; Malekela DA East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761 [TBL] [Abstract][Full Text] [Related]
3. Awareness of anti-malarial policy and malaria treatment practices of patent medicine vendors in three Nigerian states. Oladepo O; Brieger W; Adeoye B; Lawal B; Peters DH Afr J Med Med Sci; 2011 Dec; 40(4):345-52. PubMed ID: 22783684 [TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda. Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339 [TBL] [Abstract][Full Text] [Related]
5. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil. Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806 [TBL] [Abstract][Full Text] [Related]
6. [Artemether-lumefantrine, treatment of child more than 5 years old uncomplicated malaria in Tsevie's hospital (Togo)]. Djadou KE; Agbodjan-Djossou A; Azoumah KD; Djadou D; Lawson-Evi K; Balaka B; Komlangan A Arch Pediatr; 2007 Dec; 14(12):1463-4. PubMed ID: 17962001 [No Abstract] [Full Text] [Related]
7. [Efficacy of mefloquine, halofantrine, and coarteme in the treatment of tropical malaria]. Popov AF; Morokov VS; Chirkov VP; Popova NI; Lama N Med Parazitol (Mosk); 2002; (1):28-9. PubMed ID: 12224261 [No Abstract] [Full Text] [Related]
8. Artemether-lumefantrine (Coartem) for treatment of malaria. Med Lett Drugs Ther; 2009 Sep; 51(1321):75-6. PubMed ID: 19763049 [No Abstract] [Full Text] [Related]
9. Treating malaria at home in Uganda. Nakazibwe C Bull World Health Organ; 2006 Oct; 84(10):771-2. PubMed ID: 17128353 [No Abstract] [Full Text] [Related]
10. A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia. Chanda P; Masiye F; Chitah BM; Sipilanyambe N; Hawela M; Banda P; Okorosobo T Malar J; 2007 Feb; 6():21. PubMed ID: 17313682 [TBL] [Abstract][Full Text] [Related]
11. [Management of malaria in Benin: evaluation of the practices of healthcare professionals following the introduction of artemisinin derivatives]. Ogouyemi-Hounto A; Kinde-Gazard D; Nahum A; Abdillahi A; Massougbodji A Med Trop (Mars); 2009 Dec; 69(6):561-4. PubMed ID: 20099669 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Nyunt MM; Plowe CV Clin Pharmacol Ther; 2007 Nov; 82(5):601-5. PubMed ID: 17898709 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis. Jansen FH; Lesaffre E; Penali LK; Zattera MJ; Die-Kakou H; Bissagnene E Am J Trop Med Hyg; 2007 Dec; 77(6):1005-9. PubMed ID: 18165512 [TBL] [Abstract][Full Text] [Related]
14. From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia. Sipilanyambe N; Simon JL; Chanda P; Olumese P; Snow RW; Hamer DH Malar J; 2008 Jan; 7():25. PubMed ID: 18230140 [TBL] [Abstract][Full Text] [Related]
15. Impact of delayed introduction of sulfadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal, South Africa. Knight SE; Anyachebelu EJ; Geddes R; Maharaj R Trop Med Int Health; 2009 Sep; 14(9):1086-92. PubMed ID: 19624481 [TBL] [Abstract][Full Text] [Related]
16. Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial. Sykes A; Hendriksen I; Mtove G; Mandea V; Mrema H; Rutta B; Mapunda E; Manjurano A; Amos B; Reyburn H; Whitty CJ Clin Infect Dis; 2009 Oct; 49(8):1195-201. PubMed ID: 19769536 [TBL] [Abstract][Full Text] [Related]
17. Artemisinin derivatives and malaria: useful, in combination with other antimalarials. Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494 [TBL] [Abstract][Full Text] [Related]
18. FDA launches priority vouchers for neglected-disease drugs. Waltz E Nat Biotechnol; 2008 Dec; 26(12):1315-6. PubMed ID: 19060849 [No Abstract] [Full Text] [Related]
19. Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children. Adjei GO; Goka BQ; Binka F; Kurtzhals JA Expert Rev Anti Infect Ther; 2009 Aug; 7(6):669-81. PubMed ID: 19681693 [TBL] [Abstract][Full Text] [Related]
20. First Brazilian experience with the use of artemether-lumefantrine (Coartem) a fixed-dosed ACT combination. Alecrim Md; de Lacerda MV; MourĂ£o MP; Alecrim WD; Padilha A; Cardoso B; Boulos M Am J Trop Med Hyg; 2006 Aug; 75(2):187. PubMed ID: 16896116 [No Abstract] [Full Text] [Related] [Next] [New Search]